Paracetamol vs Placebo for Treating Malaria in Children
Author Information
Author(s): Kofoed Poul-Erik, Ursing Johan, Rodrigues Amabelia, Rombo Lars
Primary Institution: Projecto de Saúde de Bandim, Guinea-Bissau
Hypothesis
Does adding paracetamol to the treatment of uncomplicated malaria in children improve outcomes compared to placebo?
Conclusion
Adding paracetamol to the treatment of uncomplicated malaria in children did not significantly improve overall cure rates, but fewer children in the paracetamol group were admitted to the hospital for high fever and convulsions.
Supporting Evidence
- Fewer children in the paracetamol group were admitted to the hospital for high fever and convulsions compared to the placebo group.
- No significant differences in cumulative clinical and parasitological response rates were found between the two groups.
- The study included 338 children who met the inclusion criteria for malaria treatment.
Takeaway
The study looked at whether giving paracetamol helps kids with malaria. It found that it didn't really help them get better faster, but it might have kept some kids from having really high fevers.
Methodology
Children with malaria were randomly assigned to receive either paracetamol or placebo along with chloroquine for three days, with follow-up for symptoms and parasitaemia.
Potential Biases
Potential bias in reporting symptoms and adherence to treatment.
Limitations
The study did not find significant differences in clinical outcomes between the two groups, and the sample size may limit the generalizability of the findings.
Participant Demographics
{"age_range_months":"3 - 190","weight_range_kg":"8 - 48","gender_distribution":{"males":186,"females":162}}
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website